FDA's recent spate of proposed studies of prescription drug advertising is drawing criticism from the Pharmaceutical Research and Manufacturers of America (PhRMA), which said such research is often unnecessary given existing data.
"PhRMA remains committed to substantive research focused on prescription drug advertising and promotion. We are concerned, however, with the agency's...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?